Clinical trial

Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease

NCT03149809

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-03-01

PhasePHASE3

Study timeline

Study start (actual)2018-03-01Date precision: day

Registry last updated2024-09-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Overactive Bladderunresolved

Parkinson Diseaseunresolved

Interventions

solifenacinDRUG · verified · RxNorm: solifenacin

Pelvic floor muscle exercise-based behavioral therapyBEHAVIORAL

Sponsors & collaborators

VA Office of Research and Developmentlead sponsor

Mapped research locations

PhiladelphiaPennsylvania, United States1 BirminghamAlabama, United States1 RichmondVirginia, United States1 DecaturGeorgia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03149809 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.